Checking in with Menlo Ventures' Partner Greg Yap to get his take on the latest trends in AI in healthcare
He shares his take on topics such as how the Baby KJ news is allowing investors and companies to think about scaling bespoke therapies, how AI might start to impact the clinical trial side of our business, and why he sees pharma adoption of AI as being important.
3 hours ago
Evaluate's 2026 Orphan Drug Report
Download the free report now DOWNLOAD the FREE report #Sponsored
12 hours ago
Earli, which raised $105M in two rounds, is developing 'Cancer-Activated Promoters' that are set off by cancer-specific transcription factors and turn tumor cells into therapeutic payload factories
Co-Founder & CEO Cyriac Roeding and Co-Founder & CSO David Suhy describe the science behind this approach and explain how AI is helping they move closer to the clinic. The first IND filing is scheduled to be late '26 or early '27.
1 day ago
.png){kind=logo}
